FIXX - Homology Medicines GAAP EPS of -$0.59 beats by $0.02 revenue of $0.8M misses by $0.1M March, 23 2022 05:30 PM Homology Medicines Inc. Homology Medicines press release (NASDAQ:FIXX): Q4 GAAP EPS of -$0.59 beats by $0.02. Revenue of $0.8M misses by $0.1M. For further details see: Homology Medicines GAAP EPS of -$0.59 beats by $0.02, revenue of $0.8M misses by $0.1M